MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)

Clinical trial NCT00362024 · TERMINATED

Trial details

NCT number: NCT00362024
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2006-11-01
Primary completion: 2007-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.